In this study, we analyzed the expression profile data of patients with cervical cancer using ESTIMATE to analyze the differentially expressed genes between patients with high and low immune invasion, and co-screened them with genes with high expression in cervical cancer compared with those in the peritumoral to identify MLK4 as a possible molecular marker of cervical cancer immune invasion. The gene discussed is MAP3K21; the disease is cervical cancer.